DEBORAH PICCALUGA NUNEZ: Open Payments
NPI 1962829564 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,166 in 164 payments from 25 companies in 2025. Trend: 2023 $2,885 · 2024 $4,241 · 2025 $6,166
Food & beverage: $4,663Consulting: $1,260Travel & lodging: $153Education: $90
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $2,022 |
| AstraZeneca Pharmaceuticals LP | 31 | $1,000 |
| GlaxoSmithKline, LLC. | 23 | $379 |
| Insmed, Inc. | 10 | $334 |
| Regeneron Healthcare Solutions, Inc. | 11 | $331 |
| JAZZ PHARMACEUTICALS INC. | 10 | $325 |
| Actelion Pharmaceuticals US, Inc. | 13 | $321 |
| Verona Pharma, Inc. | 8 | $187 |
| Inspire Medical Systems, Inc. | 5 | $168 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $158 |
Products named: DUPIXENT, Arikayce, XYWAV, BREZTRI, TEZSPIRE, NUCALA, Ohtuvayre, UPTRAVI.
Industry payments across FL — which companies pay providers there.
